Theranostics · 2023 · 22 citations · 26 references
MedicineImmunologyOncologyCancer ImmunologyImmunotherapyMolecular ImagingCancer ImmunotherapyCancer NanomedicineChimeric Antigen Receptor T-cell TherapyNanomedicineNeuro-oncologic ImagingTumor ImagingCancer Immunotherapy NanoparticlesImmune Checkpoint Blockade ResistanceIron Oxide NanoparticlesNanoparticle Imaging AgentsNanoparticle Imaging ProbesT-cell TherapyT2* ImagingTumor Response Prediction
This study showcases a rational for monitoring adoptive T cell therapies non-invasively by iron oxide NP in gliomas to track intratumoral T cell influx and ultimately predict treatment outcome.
26
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
Jae H. Park, Isabelle Rivière, Mithat Gönen et al. · New England Journal of Medicine · 2018 · 2.7K citations · Full text
Life Sciences, Hematology, Oncology +17
iDISCO: A Simple, Rapid Method to Immunolabel Large Tissue Samples for Volume Imaging
Nicolas Renier, Zhuhao Wu, David Simon et al. · Cell · 2014 · 1.9K citations · Full text
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Christine E. Brown, Darya Alizadeh, Renate Starr et al. · New England Journal of Medicine · 2016 · 1.8K citations · Full text
Medicine, Immunology, Oncology +17
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas
Robbie G. Majzner, Sneha Ramakrishna, Kristen W. Yeom et al. · Nature · 2022 · 782 citations · Full text
Medicine, Immunology, Oncology +13